Diabetes drug combo tested for long-term safety in japanese patients
NCT ID NCT02622113
Summary
This study tested the long-term safety and effectiveness of adding canagliflozin (a pill) to insulin therapy for Japanese adults with type 2 diabetes. The 139 participants had already completed a 16-week study and took the medication for an additional 36 weeks. Researchers measured side effects, blood sugar control, and weight changes to see if this combination was safe and helpful over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Reserch site
Chugoku, Japan
-
Reserch site
Chūbu, Japan
-
Reserch site
Hokkaido, Japan
-
Reserch site
Kanto, Japan
-
Reserch site
Kinki, Japan
-
Reserch site
Kyushu, Japan
-
Reserch site
Tōhoku, Japan
Conditions
Explore the condition pages connected to this study.